Get the Stockscreener App
1.225
1.21%
-0.015
Heron Therapeutics Inc stock is traded at $1.225, with a volume of 835.74K.
It is down -1.21% in the last 24 hours and down -7.89% over the past month.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
See More
Previous Close:
$1.24
Open:
$1.25
24h Volume:
835.74K
Relative Volume:
0.51
Market Cap:
$224.56M
Revenue:
$137.74M
Net Income/Loss:
$-27.97M
P/E Ratio:
-7.6563
EPS:
-0.16
Net Cash Flow:
$-9.61M
1W Performance:
-3.54%
1M Performance:
-7.89%
6M Performance:
-48.74%
1Y Performance:
-35.53%
1-Day Range:
$1.21
$1.255
1-Week Range:
$1.21
$1.30
52-Week Range:
$1.04
$2.68
Heron Therapeutics Inc Stock (HRTX) Company Profile
Name
Heron Therapeutics Inc
Sector
Industry
Phone
(858) 251-4400
Address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Compare HRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.225 | 227.31M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.00 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.13 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.03 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
737.70 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.17 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-09-25 | Initiated | H.C. Wainwright | Buy |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Apr-23-24 | Initiated | CapitalOne | Overweight |
| Mar-13-24 | Reiterated | Needham | Buy |
| May-27-20 | Initiated | Guggenheim | Buy |
| Feb-20-20 | Reiterated | Needham | Buy |
| Jan-16-19 | Reiterated | Needham | Buy |
| Apr-05-18 | Initiated | Evercore ISI | Outperform |
| Mar-19-18 | Reiterated | Mizuho | Buy |
| Mar-01-18 | Reiterated | Needham | Buy |
| Jan-03-18 | Initiated | Leerink Partners | Outperform |
| Sep-27-17 | Initiated | Northland Capital | Outperform |
| Feb-27-17 | Initiated | Needham | Buy |
| Oct-26-16 | Initiated | Aegis Capital | Buy |
| Sep-06-16 | Resumed | Lake Street | Buy |
| May-03-16 | Initiated | Cantor Fitzgerald | Buy |
| Dec-10-15 | Initiated | Lake Street | Buy |
| Sep-23-15 | Reiterated | Leerink Partners | Outperform |
| Sep-02-15 | Initiated | BofA/Merrill | Buy |
| Aug-03-15 | Reiterated | Brean Capital | Buy |
| Jun-30-15 | Reiterated | JMP Securities | Mkt Outperform |
| Jun-19-15 | Reiterated | Leerink Partners | Outperform |
| Aug-07-14 | Initiated | Noble Financial | Buy |
View All
Heron Therapeutics Inc Stock (HRTX) Latest News
Aug Macro: How does Heron Therapeutics Inc compare to its peers2025 Winners & Losers & Intraday High Probability Alerts - خودرو بانک
Stock Analysis: Is Stellar V Capital Corp Debt Equity Composite Units stock influenced by commodity pricesJuly 2025 Action & Reliable Entry Point Alerts - خودرو بانک
Resistance Check: Can Heron Therapeutics Inc sustain its profitability2025 Winners & Losers & Short-Term Trading Opportunity Alerts - خودرو بانک
Earnings Risk: Why is Heron Therapeutics Inc. stock going downJuly 2025 Recap & Advanced Swing Trade Entry Alerts - خودرو بانک
Technical Analysis: Is Heron Therapeutics Inc stock technically oversold2025 Investor Takeaways & Low Drawdown Momentum Trade Ideas - خودرو بانک
Retail Trends: Is Heron Therapeutics Inc stock a good dividend stock2025 Pullback Review & Weekly Top Performers Watchlists - خودرو بانک
Heron Therapeutics files $125M mixed securities shelf - MSN
Weekly Trades: Can Heron Therapeutics Inc. expand its profit marginsEarnings Beat & Free High Accuracy Swing Entry Alerts - خودرو بانک
What candlestick patterns are forming on Heron Therapeutics Inc.Risk Management & Reliable Entry Point Trade Alerts - newser.com
Clearline Capital LP Sells 750,572 Shares of Heron Therapeutics, Inc. $HRTX - MarketBeat
Adage Capital Partners GP L.L.C. Decreases Stock Position in Heron Therapeutics, Inc. $HRTX - MarketBeat
Heron Therapeutics files for mixed shelf of up to $125 millionSEC filing - MarketScreener
Nuveen LLC Takes $691,000 Position in Heron Therapeutics, Inc. $HRTX - MarketBeat
Does Heron Therapeutics Inc. meet Warren Buffett’s criteriaJuly 2025 Momentum & Safe Entry Point Alerts - beatles.ru
Published on: 2025-09-07 00:16:22 - beatles.ru
Should I set a stop loss on Heron Therapeutics Inc.Product Launch & Free Expert Verified Stock Movement Alerts - خودرو بانک
Is Heron Therapeutics Inc.’s growth already priced inQuarterly Performance Summary & Community Driven Trade Alerts - خودرو بانک
Can Heron Therapeutics Inc. hit a new high this month2025 Dividend Review & Breakout Confirmation Trade Signals - Newser
Relative strength of Heron Therapeutics Inc. in sector analysisInflation Watch & Weekly Stock Performance Updates - Newser
Can Heron Therapeutics Inc. expand its profit marginsJuly 2025 Drop Watch & Accurate Buy Signal Notifications - خودرو بانک
Trend analysis for Heron Therapeutics Inc. this weekJuly 2025 Update & Fast Gain Stock Trading Tips - Newser
How to track smart money flows in Heron Therapeutics Inc.2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser
Quantitative breakdown of Heron Therapeutics Inc. recent movePrice Action & Stepwise Entry/Exit Trade Alerts - Newser
Combining machine learning predictions for Heron Therapeutics Inc.2025 Historical Comparison & Reliable Price Breakout Signals - Newser
Will Heron Therapeutics Inc. stock go up soonPortfolio Risk Summary & High Yield Equity Trading Tips - Newser
Using flow based indicators on Heron Therapeutics Inc.Quarterly Performance Summary & Precise Swing Trade Alerts - Newser
When is the best time to exit Heron Therapeutics Inc.2025 Top Decliners & Free High Return Stock Watch Alerts - Newser
Published on: 2025-09-04 09:42:08 - Newser
Can you recover from losses in Heron Therapeutics Inc.July 2025 Levels & Reliable Entry Point Alerts - Newser
What the charts say about Heron Therapeutics Inc. today2025 Valuation Update & AI Powered Market Trend Analysis - Newser
Will Heron Therapeutics Inc. outperform the marketJuly 2025 Momentum & Daily Profit Focused Screening - Newser
Is Heron Therapeutics Inc. stock ready for a breakoutWeekly Trade Recap & Risk Controlled Swing Alerts - Newser
Why is Heron Therapeutics Inc. stock going downWeekly Profit Analysis & Verified Stock Trade Ideas - خودرو بانک
Can machine learning forecast Heron Therapeutics Inc. recoveryPortfolio Value Report & Stock Portfolio Risk Control - Newser
Applying big data sentiment scoring on Heron Therapeutics Inc.Market Volume Report & Free Weekly Chart Analysis and Trade Guides - Newser
Heron Therapeutics Inc. stock outlook for YEAR2025 EndofYear Setup & High Conviction Trade Alerts - Newser
Will Heron Therapeutics Inc. continue its uptrend2025 Breakouts & Breakdowns & High Conviction Trade Alerts - Newser
How institutional ownership impacts Heron Therapeutics Inc. stockJuly 2025 Review & Daily Technical Forecast Reports - Newser
Analyzing Heron Therapeutics Inc. with multi timeframe chartsWeekly Volume Report & Community Shared Stock Ideas - Newser
Heron Therapeutics Inc Stock (HRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Heron Therapeutics Inc Stock (HRTX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Morgan Adam | Director |
Aug 08 '25 |
Buy |
1.50 |
1,766,546 |
2,649,819 |
8,753,290 |
0.69%
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):